Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Investigators observed that SOX9, a transcription factor and stem cell/glial fate marker, is limited to rare, quiescent cells in high-risk medulloblastoma with MYC amplification.